News and updates from the Big4 Space for Big4 Alumni.
Saturday, June 16, 2018
Sirtex expects approval for $1.4bn China buyout
Australian liver cancer treatment maker Sirtex Medical Ltd expects its $1.4bn buyout by a Chinese consortium will win regulatory approval in Australia ...
No comments:
Post a Comment